Carprieve 20 mg Flavoured Tablets for Dogs

Nazione: Irlanda

Lingua: inglese

Fonte: HPRA (Health Products Regulatory Authority)

Compra

Scarica Scheda tecnica (SPC)
12-06-2017

Principio attivo:

Carprofen

Commercializzato da:

Norbrook Laboratories Limited

Codice ATC:

QM01AE91

INN (Nome Internazionale):

Carprofen

Dosaggio:

20 mg/tablet

Forma farmaceutica:

Tablet

Tipo di ricetta:

POM: Prescription Only Medicine as defined in relevant national legislation

Gruppo terapeutico:

Dogs

Area terapeutica:

carprofen

Indicazioni terapeutiche:

N.S.A.I.D.

Stato dell'autorizzazione:

Authorised

Data dell'autorizzazione:

2011-03-21

Scheda tecnica

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Carprieve 20 mg Flavoured Tablets for Dogs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCE:
Carprofen
20mg
EXCIPIENTS:
For the full list of excipients see section 6.1
3 PHARMACEUTICAL FORM
Tablet.
Light brown, round, flat, bevel edged tablet.
The tablets can be divided into equal parts.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For analgesia and reduction of chronic inflammation, for example in
degenerative joint disease in the dog.
The tablets also can be used in the management of post operative pain.
4.3 CONTRAINDICATIONS
Do not exceed the stated dose.
Do not use in cats.
Do not
use in dogs suffering from cardiac,
hepatic or renal
disease,
where there is a possibility of gastrointestinal
ulceration or bleeding, or where there is evidence of blood dyscrasia
or hypersensitivity to the product.
Do not use in puppies less than 4 months.
Do not use in cases of hypersensitivity to active substance or to any
of the excipients.
Refer to section 4.7 and 4.8
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
See sections 4.3 and 4.5.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_0_
_/_
_0_
_5_
_/_
_2_
_0_
_1_
_6_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_1_
_3_
_1_
_1_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
i.
Special precautions for use in animals:
Use in aged dogs may involve addit
                                
                                Leggi il documento completo
                                
                            

Cerca alert relativi a questo prodotto